| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| clazosentan | endothelin-1 receptor | small molecule | NA | drugbank , DGIDB | Cerebrovascular accident[MeSHID:D020521] Vascular constriction (function)[MeSHID:D014661] Cerebral Vasospasm[MeSHID:D020301] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
14.14 | investigational | antagonist |
| clazosentan | endothelin-1 receptor | small molecule | NA | drugbank , DGIDB | Cerebrovascular accident[MeSHID:D020521] Vascular constriction (function)[MeSHID:D014661] Cerebral Vasospasm[MeSHID:D020301] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
14.14 | investigational | unknown |
| clazosentan | endothelin a receptor | NA | Successful target | TTD , DGIDB | Cerebrovascular accident[MeSHID:D020521] Vascular constriction (function)[MeSHID:D014661] Cerebral Vasospasm[MeSHID:D020301] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
14.14 | phase 3 | antagonist |
| clazosentan | endothelin a receptor | NA | Successful target | TTD , DGIDB | Cerebrovascular accident[MeSHID:D020521] Vascular constriction (function)[MeSHID:D014661] Cerebral Vasospasm[MeSHID:D020301] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
14.14 | phase 3 | unknown |
| click here to return to the previous page | ||||||||